Slide 1: Q1 2026 Earnings Presentation
Q1 2026 Earnings Presentation April 30, 2026 Q1 2026 Earnings Presentation FMC CORPORATION 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements made in this presentation are forward- looking statements that are based on our current views and assumptions regarding future events, future business conditions and the outlook
Slide 3: FMC Advancing on 2026 Operational Priorities
FMC Advancing on 2026 Operational Priorities Company continues to focus on operational priorities as exploration of strategic options occurs in parallel Improve ~$1B of Targeted Debt Continue Post-Patent Grow Sales of New Competitiveness of Paydown Rynaxypyr® Strategy Active Ingredients Core Portfol
Slide 4: Q1 2026 Results
Q1 2026 Results Q1 2026 Q1 20252 2026 VS. 20253 GAAP Revenue $759 $791 (4)% Revenue ex. India1 $762 (4)% GAAP Net Income $(281) $(16) $(266) Adjusted EBITDA1 $72 $120 (40)% % Revenue (ex. ’26 India) 9.5% 15.1% (570) bps GAAP EPS $(2.25) $(0.12) $(2.13) Adjusted EPS1 $(0.23) $0.18 $(0.41) Note: Amoun
Slide 5: Regional Revenue Drivers
Q1 2026 Regional Revenue Drivers Sales improved 1% excluding prior year India contribution REGIONAL REVENUE BRIDGE (Excluding India)1 North $198 million Latin $177 million (6% YoY, (-14% YoY, America 4% ex-FX) America -21% ex-FX) $791 $754 $11 $34 $762 • High-teens sales growth for all • Lower brand
Slide 6: Adjusted EBITDA Drivers
Q1 2026 Adjusted EBITDA1 Drivers Adjusted EBITDA1 BRIDGE $11 $120 $120 ($0) $21 $72 ($50) ($30) Q1 ‘25 India India Q1 ‘25 ex. Volume, Mix,… Volume, Mix, Price Cost Cost FX Q1 ‘26 Q1 '26 Q1 '25 India Q1 '25 ex. India Launches Price FX Note: Amounts in millions of USD KEY DRIVERS AT A GLANCE Volume, M
Slide 7: Q2 2026 Financial Outlook
Q2 2026 Financial Outlook Q2 2026 Guidance REVENUE Excl. India1 DRIVERS Lower YoY sales almost entirely due to partner sales and the removal of India REVENUE excl. India1 • Mid-single digit price decline • Lower volume primarily from reduced orders from $850 million – • Competitive pressure for lega
Slide 8: FY 2026 Financial Outlook
FY 2026 Financial Outlook FY 2026 Guidance REVENUE excl. India1 REVENUE (excl. India)1 DRIVERS • Price down mid-single digits mainly due to Rynaxypyr® $3.60 billion – • Excluding India, volume is modestly higher $3.80 billion • India represents a 2 percent headwind (5)% YoY3 • FX neutral ADJ. EBITDA
Slide 9: H2 2026 Financial Outlook
H2 2026 Financial Outlook H2 sales consistent with prior year; positive business indicators providing confidence in outlook H2 2026 Guidance REVENUE excl. India1 REVENUE (excl. India)1 DRIVERS • Volume growth driven by new products with more committed orders in key countries than prior year $1.99 bi
Slide 10: H2 Adj. EBITDA Outlook In Line with Prior Year
H2 Adj. EBITDA1 Outlook In Line with Prior Year Volume growth driven by increase in new actives $516M $468M - $508M -6% vs. PY at midpoint 1 1 H2 2025 Adj. EBITDA Volume (New Actives) Volume (All Other) Price Cost & FX H2 2026 Adj. EBITDA • New active ingredients responsible for roughly two-thirds o
Slide 11: Q1 Cash Results and 2026 Cash Flow Guidance
Q1 Cash Results and 2026 Cash Flow Guidance Q1 ’26 In Millions Q1 ‘26 Q1 ‘25 FY 2026 Guidance vs. Q1 ’25 Adjusted EBITDA1 $72 $120 $(48) $670 - $730 Q1 Cash Results Cash from Operations (GAAP) $(601) $(545) $(56) $90 - $260 • Lower cash from operations due mainly to lower y/y EBITDA1 Capital Additio
Slide 12: FMC CORPORATION
Q1 2026 Earnings Presentation FMC CORPORATION 12
Slide 13: Modeling Assumptions for 2026
Modeling Assumptions for 2026 Appendix $255 million – 16 – 18 $1 million – Revenue: ~$90 million EBITDA: $0 million $275 million percent $3 million INTEREST EXPENSE NON-CONTROLLING INTEREST 2026 EXPECTED INDIA LOSS OF ADJUSTED TAX RATE1 CONTRIBUTION ~125.9 $160 million – $(65) million – $90 – $110 m
Slide 14: Adjusted EPS Variance
Q1 2026 Adjusted EPS1 Variance Appendix $0.18 $(0.33) $(0.10) $0.01 $0.01 $(0.23) Q1 ‘25 Adj. EBITDA1 INT. EXPENSE D&A OTHER Q1 ‘26 1. Denotes non-GAAP financial term. Refer to non-GAAP financial terms at the beginning of this presentation Q1 2026 Earnings Presentation FMC CORPORATION 14
Slide 15: Additional Disclaimers
Additional Disclaimers Always read and follow all label directions, restrictions and precautions for use. Products listed here may not be registered for sale or use in all states, countries or jurisdictions. No offer for sale, sale, or use of any such products is permitted prior to the issuance of t
Slide 16: FMC CORPORATION
Copyright © 2026, FMC Corporation. All Rights Reserved. Q1 2026 Earnings Presentation FMC CORPORATION 16